Electromagnetic Environmental Effects Testing of Medical Devices Including Those Used for the Treatment of Diabetes

Abstract

Background:

Electromagnetic emissions from technologies that surround us can produce interference with implanted and externally worn medical devices. Electromagnetic environmental effects (E3) testing of medical devices at the Georgia Tech Research Institute (GTRI) began almost four decades ago and continues to incorporate new devices and new sources of electromagnetic emissions as they are developed and become available. The GTRI Medical Device Test Center provides real-world exposure fields to identify interactions and help manufacturers prevent disruptions from the environments in which their devices must function.

Methods:

Typically, the medical device is mounted in or on a torso simulator containing a saline solution that simulates the electrical characteristics of the body. The torso simulator and the device under test are then moved through the fields generated by production security and logistical system technologies using a computer-controlled positioning system. These tests are conducted with different orientations of the medical device to the electromagnetic source, simulating the way in which device wearers interact with these systems in representative situations.

Results:

Particular E3 test results measured on specific devices in the GTRI Medical Device Test Center are proprietary; however, the results of tests to date with current medical devices used for the treatment of diabetes have been encouraging. These devices have included implantable and externally worn insulin infusion pumps and continuous glucose monitoring systems from different manufacturers.

Conclusion:

Since E3 tests of diabetes treatment devices to date in the test center have centered on devices from only a few of the many current manufacturers, further testing is warranted. In addition, increased functionality, which is being added to existing devices, will create new possibilities for interference in the future.

Keywords

continuous glucose monitoring system diabetes electromagnetic E3 insulin infusion pump medical device testing

References

Pacemaker standard—labeling requirements, performance requirements, and terminology for implantable artificial cardiac pacemakers, FDA Contract No. 223–74–5083, Association for the Advancement of Medical Instrumentation (AAMI), August 1975.

Herkert

Woody

Denny

. E3 testing of implantable medical devices—past and present. Chicago, IL: Proc. IEEE Eng Med Biol Soc. Vol 19; 1997.

Herkert

Woody

. Implantable medical device testing to EAS environments and applying lessons learned to RFID and other security and logistical system technologies. Orlando, FL: Fifth RFID Academic Convocation; 2007.

Important Information on anti-theft and metal detector systems and pacemakers, ICDs, and spinal cord stimulators. U.S. Food and Drug Administration, Center for Devices and Radiological Health, September 28, 1998. Available from: http://www.fda.gov/cdrh/safety/easnote.html.

Gimbel

Cox

Jr.

Electronic article surveillance systems and interactions with implanted cardiac devices: risk of adverse interactions in public and commercial spaces. Mayo Clin Proc. 2007;82 (3): 318–22.

Examination of effects of radio waves from RFID devices on implanted cardiac pacemakers etc. Japan Automatic Identification Systems Association (JAISA), RFID Technical Committee, March 15, 2006.

Seidman

Ruggera

Brockman

Mitchell

Shein

. Electromagnetic compatibility of pacemakers and implantable cardiac defibrillators exposed to RFID readers. Orlando, FL: Fifth RFID Academic Convocation; 2007.

E3 Test Protocol for Medical Devices to Security and Logistical Systems, Ver. 5.1. Medical Device Test Center, Georgia Tech Research Institute, Atlanta, GA, August 2007.